Researchers
Dragičević, Dejan
Results 1-20 of 93
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2023 | Polymorphisms of Antioxidant Enzymes SOD2 (rs4880) and GPX1 (rs1050450) Are Associated with Bladder Cancer Risk or Its Aggressiveness![]() | Nikić, Predrag Z. | Article | 21M21 |
| 2022 | The Association of Polymorphisms in Genes Encoding Antioxidant Enzymes GPX1 (rs1050450), SOD2 (rs4880) and Transcriptional Factor Nrf2 (rs6721961) with the Risk and Development of Prostate Cancer![]() | Đokić, Milica; Radić, Tanja | Article | 21M21 |
| 2022 | Re: An Integrated Multi-Omics Analysis Identifies Prognostic Molecular Subtypes of Non-Muscle Invasive Bladder Cancer Editorial Comment![]() | Lindskrog, Sia Viborg; ...; Groeneveld, Clarice S.; ...; Weyerer, Veronika; ...; Dragičević, Dejan P.
(broj koautora 47);
| Other | Mp. category will be shown later |
| 2021 | An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer![]() | Lindskrog, Sia Viborg; ...; Dragičević, Dejan P. | Article | 21a+M21a+ |
| 2021 | Polymorphisms in Genes Encoding Glutathione Transferase Pi and Glutathione Transferase Omega Influence Prostate Cancer Risk and Prognosis![]() | Santrić Veljko | Article | 21M21 |
| 2021 | Prognostic value of Balkan endemic nephropathy and gender on upper tract urothelial carcinoma outcomes after radical nephroureterectomy: A cohort study![]() | Milojević, Bogomir D. | Article | 21M21 |
| 2021 | Prognostic significance of tumor multifocality on outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy: A cohort study![]() | Milojević, Bogomir D. | Article | 22M22 |
| 2021 | The Association of Polymorphisms in Nrf2 and Genes Involved in Redox Homeostasis in the Development and Progression of Clear Cell Renal Cell Carcinoma![]() | Mihailovic, Smiljana; Coric, Vesna M | Article | 21M21 |
| 2020 | Tumori gornjeg urotelijuma - epidemiologija i kliničke karakteristike![]() | Dragičević, Dejan | Book parts | Mp. category will be shown later |
| 2020 | GSTP1 rs1138272 Polymorphism Affects Prostate Cancer Risk![]() | Šantrić, Veljko | Article | 21M21 |
| 2019 | GSTP1*G/GSTP1*T and GSTO1*A/GSTO2*G haplotypes affect the prostate cancer risk![]() | Savic-Radojevic, Ana R | Conference Paper | Mp. category will be shown later |
| 2019 | GSTO1*CC genotype (rs4925) predicts shorter survival in clear cell renal cell carcinoma![]() | Radić, Tanja M. | Conference Paper | 34 MNO za medicinske nauke (12.06.2024.)M34 |
| 2019 | Polymorphisms and expression of omega class glutathione transferases in clear cell renal cell carcinoma![]() | Radić, Tanja M. | Conference Paper | 34 MNO za medicinske nauke (12.06.2024.)M34 |
| 2019 | Prognostički značaj glutation transferaza klase omega u svetloćelijskom karcinomu bubrežnog parenhima![]() | Radić, Tanja M. | Conference Paper | 64 MNO za medicinske nauke (12.06.2024.)M64 |
| 2019 | Disturbed redox balance contributes clear cell renal cell carcinima development and progression![]() | Ćorić, Vesna M. | Conference Paper | 34 MNO za medicinske nauke (12.06.2024.)M34 |
| 2019 | Association of SOD2 (rs4880) and GPX1 (rs1050450) Gene Polymorphisms with Risk of Balkan Endemic Nephropathy and its Related Tumors![]() | Dragičević, Biljana; Šuvakov, Sonja | Article | 22M22 |
| 2019 | GSTP1 affects the development and progression of clear cell renal cell carcinoma![]() | Plješa-Ercegovac, Marija | Conference Paper | 34 MNO za medicinske nauke (12.06.2024.)M34 |
| 2019 | GSTO1 (rs4925) polymorphism might be determinant of postoperative prognosis among male clear cell renal cell carcinoma patients![]() | Radić, Tanja M. | Conference Paper | 34 MNO za medicinske nauke (12.06.2024.)M34 |
| 2019 | GSTO1*CC Genotype (rs4925) Predicts Shorter Survival in Clear Cell Renal Cell - Carcinoma Male Patients![]() | Radić, Tanja M. | Article | 21aM21a |
| 2018 | Concomitance of polymorphisms in glutathione transferase omega genes is associated with renal cell carcinoma risk and progression![]() | Radić, Tanja | Conference Paper | 34 MNO za medicinske nauke (12.06.2024.)M34 |

